{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:41:25Z","timestamp":1790260885790,"version":"4.1.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-020-0237-2","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T18:53:19Z","timestamp":1593543199000},"page":"572-585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":251,"title":["A metabolic handbook for the COVID-19 pandemic"],"prefix":"10.1038","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0809-2494","authenticated-orcid":false,"given":"Janelle S.","family":"Ayres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"237_CR1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nri2432","volume":"8","author":"DS Schneider","year":"2008","unstructured":"Schneider, D. S. & Ayres, J. S. Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 8, 889\u2013895 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"237_CR2","doi-asserted-by":"crossref","first-page":"eabc1518","DOI":"10.1126\/sciadv.abc1518","volume":"6","author":"JS Ayres","year":"2020","unstructured":"Ayres, J. S. Surviving COVID-19: a disease tolerance perspective. Sci. Adv. 6, eabc1518 (2020).","journal-title":"Sci. Adv."},{"key":"237_CR3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","volume":"39","author":"HK Siddiqi","year":"2020","unstructured":"Siddiqi, H. K. & Mehra, M. R. COVID-19 illness in native and immunosuppressed states: a clinical\u2013therapeutic staging proposal. J. Heart Lung Transplant. 39, 405\u2013407 (2020).","journal-title":"J. Heart Lung Transplant."},{"key":"237_CR4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41577-019-0266-9","volume":"20","author":"JS Ayres","year":"2020","unstructured":"Ayres, J. S. Immunometabolism of infections. Nat. Rev. Immunol. 20, 79\u201380 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"237_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.it.2019.12.001","volume":"41","author":"K Troha","year":"2020","unstructured":"Troha, K. & Ayres, J. S. Metabolic adaptations to infections at the organismal level. Trends Immunol. 41, 113\u2013125 (2020).","journal-title":"Trends Immunol."},{"key":"237_CR6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2020.03.036","volume":"181","author":"JS Ayres","year":"2020","unstructured":"Ayres, J. S. The biology of physiological health. Cell 181, 250\u2013269 (2020).","journal-title":"Cell"},{"key":"237_CR7","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.cell.2016.07.026","volume":"166","author":"A Wang","year":"2016","unstructured":"Wang, A. et al. Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation. Cell 166, 1512\u20131525.e1512 (2016).","journal-title":"Cell"},{"key":"237_CR8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.aac6468","volume":"350","author":"AM Schieber","year":"2015","unstructured":"Schieber, A. M. et al. Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling. Science 350, 558\u2013563 (2015).","journal-title":"Science"},{"key":"237_CR9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cell.2017.01.006","volume":"168","author":"S Rao","year":"2017","unstructured":"Rao, S. et al. Pathogen-mediated inhibition of anorexia promotes host survival and transmission. Cell 168, 503\u2013516.e512 (2017).","journal-title":"Cell"},{"key":"237_CR10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2018.07.016","volume":"175","author":"KK Sanchez","year":"2018","unstructured":"Sanchez, K. K. et al. Cooperative metabolic adaptations in the host can favor asymptomatic infection and select for attenuated virulence in an enteric pathogen. Cell 175, 146\u2013158.e115 (2018).","journal-title":"Cell"},{"key":"237_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41574-020-0353-9","volume":"16","author":"SR Bornstein","year":"2020","unstructured":"Bornstein, S. R., Dalan, R., Hopkins, D., Mingrone, G. & Boehm, B. O. Endocrine and metabolic link to coronavirus infection. Nat. Rev. Endocrinol. 16, 297\u2013298 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"237_CR12","doi-asserted-by":"publisher","unstructured":"Yu, X. & Yang, R. COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza Other Respir. Viruses https:\/\/doi.org\/10.1111\/irv.12743 (2020).","DOI":"10.1111\/irv.12743"},{"key":"237_CR13","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1001\/jama.289.21.JOC30885","volume":"289","author":"CM Booth","year":"2003","unstructured":"Booth, C. M. et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289, 2801\u20132809 (2003).","journal-title":"JAMA"},{"key":"237_CR14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","volume":"23","author":"JK Yang","year":"2006","unstructured":"Yang, J. K. et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet. Med. 23, 623\u2013628 (2006).","journal-title":"Diabet. Med."},{"key":"237_CR15","doi-asserted-by":"crossref","first-page":"E575","DOI":"10.3390\/jcm9020575","volume":"9","author":"SQ Deng","year":"2020","unstructured":"Deng, S. Q. & Peng, H. J. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J. Clin. Med. 9, E575 (2020).","journal-title":"J. Clin. Med."},{"key":"237_CR16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061\u20131069 (2020).","journal-title":"JAMA"},{"key":"237_CR17","doi-asserted-by":"publisher","unstructured":"Zhang, J. J. et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy https:\/\/doi.org\/10.1111\/all.14238 (2020).","DOI":"10.1111\/all.14238"},{"issue":"Suppl. 1","key":"237_CR18","first-page":"S27","volume":"16","author":"J Casqueiro","year":"2012","unstructured":"Casqueiro, J., Casqueiro, J. & Alves, C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J. Endocrinol. Metab. 16 (Suppl. 1), S27\u2013S36 (2012).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"237_CR19","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(20)31024-2","volume":"395","author":"DA Kass","year":"2020","unstructured":"Kass, D. A., Duggal, P. & Cingolani, O. Obesity could shift severe COVID-19 disease to younger ages. Lancet 395, 1544\u20131545 (2020).","journal-title":"Lancet"},{"key":"237_CR20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-immunol-020711-075030","volume":"30","author":"JS Ayres","year":"2012","unstructured":"Ayres, J. S. & Schneider, D. S. Tolerance of infections. Annu. Rev. Immunol. 30, 271\u2013294 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"237_CR21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1900\/RDS.2015.12.110","volume":"12","author":"K Tziomalos","year":"2015","unstructured":"Tziomalos, K. & Athyros, V. G. Diabetic nephropathy: new risk factors and improvements in diagnosis. Rev. Diabet. Stud. 12, 110\u2013118 (2015).","journal-title":"Rev. Diabet. Stud."},{"key":"237_CR22","doi-asserted-by":"crossref","first-page":"132405","DOI":"10.4061\/2011\/132405","volume":"2011","author":"FM Tedla","year":"2011","unstructured":"Tedla, F. M., Brar, A., Browne, R. & Brown, C. Hypertension in chronic kidney disease: navigating the evidence. Int. J. Hypertens 2011, 132405 (2011).","journal-title":"Int. J. Hypertens"},{"key":"237_CR23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11255-020-02451-9","volume":"52","author":"BM Henry","year":"2020","unstructured":"Henry, B. M. & Lippi, G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int. Urol. Nephrol. 52, 1193\u20131194 (2020).","journal-title":"Int. Urol. Nephrol."},{"key":"237_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2020.04.077","volume":"87","author":"A Avula","year":"2020","unstructured":"Avula, A. et al. COVID-19 presenting as stroke. Brain Behav. Immun. 87, 115\u2013119 (2020).","journal-title":"Brain Behav. Immun."},{"key":"237_CR25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","volume":"126","author":"A Akhmerov","year":"2020","unstructured":"Akhmerov, A. & Marb\u00e1n, E. COVID-19 and the heart. Circ. Res. 126, 1443\u20131455 (2020).","journal-title":"Circ. Res."},{"key":"237_CR26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2337\/db09-1600","volume":"59","author":"ER Seaquist","year":"2010","unstructured":"Seaquist, E. R. The final frontier: how does diabetes affect the brain? Diabetes 59, 4\u20135 (2010).","journal-title":"Diabetes"},{"issue":"Suppl. 2","key":"237_CR27","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.2337\/dc11-s248","volume":"34","author":"LM Ruilope","year":"2011","unstructured":"Ruilope, L. M. & Solini, A. RAS blockade for every diabetic patient: pro and con. Diabetes Care 34 (Suppl. 2), S320\u2013S324 (2011).","journal-title":"Diabetes Care"},{"key":"237_CR28","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.2337\/db10-1205","volume":"59","author":"D Batlle","year":"2010","unstructured":"Batlle, D., Jose Soler, M. & Ye, M. ACE2 and diabetes: ACE of ACEs? Diabetes 59, 2994\u20132996 (2010).","journal-title":"Diabetes"},{"key":"237_CR29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mce.2008.09.020","volume":"302","author":"SM Bindom","year":"2009","unstructured":"Bindom, S. M. & Lazartigues, E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol. Cell. Endocrinol. 302, 193\u2013202 (2009).","journal-title":"Mol. Cell. Endocrinol."},{"key":"237_CR30","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","volume":"31","author":"L Zhu","year":"2020","unstructured":"Zhu, L. et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 31, 1068\u20131077.e3 (2020).","journal-title":"Cell Metab."},{"key":"237_CR31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/thx.2004.035972","volume":"60","author":"JC Chan","year":"2005","unstructured":"Chan, J. C. Recovery pathway of post-SARS patients. Thorax 60, 361\u2013362 (2005).","journal-title":"Thorax"},{"key":"237_CR32","volume":"7","author":"Q Wu","year":"2017","unstructured":"Wu, Q. et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci. Rep. 7, 9110 (2017).","journal-title":"Sci. Rep."},{"key":"237_CR33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","volume":"47","author":"JK Yang","year":"2010","unstructured":"Yang, J. K., Lin, S. S., Ji, X. J. & Guo, L. M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 47, 193\u2013199 (2010).","journal-title":"Acta Diabetol."},{"key":"237_CR34","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.mayocp.2016.12.020","volume":"92","author":"CJ Jivanji","year":"2017","unstructured":"Jivanji, C. J., Asrani, V. M., Windsor, J. A. & Petrov, M. S. New-onset diabetes after acute and critical illness: a systematic review. Mayo Clin. Proc. 92, 762\u2013773 (2017).","journal-title":"Mayo Clin. Proc."},{"key":"237_CR35","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.2337\/dc17-2409","volume":"41","author":"YF Lin","year":"2018","unstructured":"Lin, Y. F. et al. New-onset diabetes after acute kidney injury requiring dialysis. Diabetes Care 41, 2105\u20132110 (2018).","journal-title":"Diabetes Care"},{"key":"237_CR36","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-019-2626-z","volume":"23","author":"C Sasannejad","year":"2019","unstructured":"Sasannejad, C., Ely, E. W. & Lahiri, S. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit. Care 23, 352 (2019).","journal-title":"Crit. Care"},{"key":"237_CR37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s13679-018-0296-9","volume":"7","author":"S Higgs","year":"2018","unstructured":"Higgs, S. & Spetter, M. S. Cognitive control of eating: the role of memory in appetite and weight gain. Curr. Obes. Rep 7, 50\u201359 (2018).","journal-title":"Curr. Obes. Rep"},{"key":"237_CR38","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/CCM.0000000000001621","volume":"44","author":"M Huang","year":"2016","unstructured":"Huang, M. et al. Psychiatric symptoms in acute respiratory distress syndrome survivors: a 1-year national multicenter study. Crit. Care Med. 44, 954\u2013965 (2016).","journal-title":"Crit. Care Med."},{"key":"237_CR39","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/CCM.0000000000003183","volume":"46","author":"KS Chan","year":"2018","unstructured":"Chan, K. S. et al. Evaluating muscle mass in survivors of acute respiratory distress syndrome: a 1-year multicenter longitudinal study. Crit. Care Med. 46, 1238\u20131246 (2018).","journal-title":"Crit. Care Med."},{"key":"237_CR40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10145","volume":"6","author":"P Rocheteau","year":"2015","unstructured":"Rocheteau, P. et al. Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy. Nat. Commun. 6, 10145 (2015).","journal-title":"Nat. Commun."},{"key":"237_CR41","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00134-016-4530-1","volume":"42","author":"ER Pfoh","year":"2016","unstructured":"Pfoh, E. R. et al. Physical declines occurring after hospital discharge in ARDS survivors: a 5-year longitudinal study. Intensive Care Med 42, 1557\u20131566 (2016).","journal-title":"Intensive Care Med"},{"key":"237_CR42","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3201\/eid2607.200445","volume":"26","author":"M Jin","year":"2020","unstructured":"Jin, M. & Tong, Q. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg. Infect. Dis. 26, 1618\u20131620 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"237_CR43","doi-asserted-by":"publisher","unstructured":"Haley, M. J. et al. Stroke induces prolonged changes in lipid metabolism, the liver and body composition in mice. Transl. Stroke Res. https:\/\/doi.org\/10.1007\/s12975-019-00763-2 (2019).","DOI":"10.1007\/s12975-019-00763-2"},{"key":"237_CR44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","volume":"20","author":"KK To","year":"2020","unstructured":"To, K. K. et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect. Dis. 20, 565\u2013574 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"237_CR45","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","volume":"26","author":"X He","year":"2020","unstructured":"He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 26, 672\u2013675 (2020).","journal-title":"Nat. Med."},{"key":"237_CR46","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","volume":"382","author":"L Zou","year":"2020","unstructured":"Zou, L. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 382, 1177\u20131179 (2020).","journal-title":"N. Engl. J. Med."},{"key":"237_CR47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"237_CR48","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/cid\/cis636","volume":"55","author":"JK Louie","year":"2012","unstructured":"Louie, J. K. et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin. Infect. Dis. 55, 1198\u20131204 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"237_CR49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar, R. et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19, 181\u2013193 (2016).","journal-title":"Cell Host Microbe"},{"key":"237_CR50","first-page":"690950","volume":"2014","author":"M Sun","year":"2014","unstructured":"Sun, M. et al. Metabolic effects of social isolation in adult C57BL\/6 mice. Int. Sch. Res. Notices 2014, 690950 (2014).","journal-title":"Int. Sch. Res. Notices"},{"key":"237_CR51","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-017-4948-6","volume":"17","author":"S Brinkhues","year":"2017","unstructured":"Brinkhues, S. et al. Socially isolated individuals are more prone to have newly diagnosed and prevalent type 2 diabetes mellitus: the Maastricht study. BMC Public Health 17, 955 (2017).","journal-title":"BMC Public Health"},{"key":"237_CR52","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3389\/fphys.2016.00616","volume":"7","author":"TM Altenburg","year":"2016","unstructured":"Altenburg, T. M., Rotteveel, J., Sern\u00e9, E. H. & Chinapaw, M. J. Effects of multiple sedentary days on metabolic risk factors in free-living conditions: lessons learned and future recommendations. Front. Physiol. 7, 616 (2016).","journal-title":"Front. Physiol."},{"key":"237_CR53","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fpubh.2018.00258","volume":"6","author":"S Panahi","year":"2018","unstructured":"Panahi, S. & Tremblay, A. Sedentariness and health: is sedentary behavior more than just physical inactivity? Front. Public Health 6, 258 (2018).","journal-title":"Front. Public Health"},{"key":"237_CR54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4093\/dmj.2012.36.3.207","volume":"36","author":"IK Jeong","year":"2012","unstructured":"Jeong, I. K. The role of cortisol in the pathogenesis of the metabolic syndrome. Diabetes Metab. J. 36, 207\u2013210 (2012).","journal-title":"Diabetes Metab. J."},{"key":"237_CR55","doi-asserted-by":"crossref","first-page":"20140116","DOI":"10.1098\/rstb.2014.0116","volume":"370","author":"PM Kappeler","year":"2015","unstructured":"Kappeler, P. M., Cremer, S. & Nunn, C. L. Sociality and health: impacts of sociality on disease susceptibility and transmission in animal and human societies. Phil. Trans. R. Soc. Lond. B 370, 20140116 (2015).","journal-title":"Phil. Trans. R. Soc. Lond. B"},{"key":"237_CR56","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.367.6485.1412","volume":"367","author":"K Kupferschmidt","year":"2020","unstructured":"Kupferschmidt, K. & Cohen, J. Race to find COVID-19 treatments accelerates. Science 367, 1412\u20131413 (2020).","journal-title":"Science"},{"key":"237_CR57","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.cell.2020.04.013","volume":"181","author":"B Oberfeld","year":"2020","unstructured":"Oberfeld, B. et al. SnapShot: COVID-19. Cell 181, 954\u2013954.e1 (2020).","journal-title":"Cell"},{"key":"237_CR58","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.3390\/v11010073","volume":"11","author":"B Yan","year":"2019","unstructured":"Yan, B. et al. Characterization of the lipidomic profile of human coronavirus-infected cells: implications for lipid metabolism remodeling upon coronavirus replication. Viruses 11, E73 (2019).","journal-title":"Viruses"},{"key":"237_CR59","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3389\/fimmu.2019.01533","volume":"10","author":"KA Mayer","year":"2019","unstructured":"Mayer, K. A., St\u00f6ckl, J., Zlabinger, G. J. & Gualdoni, G. A. Hijacking the supplies: metabolism as a novel facet of virus-host interaction. Front. Immunol. 10, 1533 (2019).","journal-title":"Front. Immunol."},{"key":"237_CR60","volume":"10","author":"S Yuan","year":"2019","unstructured":"Yuan, S. et al. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nat. Commun. 10, 120 (2019).","journal-title":"Nat. Commun."},{"key":"237_CR61","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.celrep.2017.04.039","volume":"19","author":"HS Smallwood","year":"2017","unstructured":"Smallwood, H. S. et al. Targeting metabolic reprogramming by influenza infection for therapeutic intervention. Cell Rep. 19, 1640\u20131653 (2017).","journal-title":"Cell Rep."},{"key":"237_CR62","doi-asserted-by":"publisher","unstructured":"Bojkova, J. et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature https:\/\/doi.org\/10.1038\/s41586-020-2332-7 (2020).","DOI":"10.1038\/s41586-020-2332-7"},{"key":"237_CR63","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045.e1039 (2020).","journal-title":"Cell"},{"key":"237_CR64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2019.05.003","volume":"178","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. Lactate is a natural suppressor of RLR signaling by targeting MAVS. Cell 178, 176\u2013189.e115 (2019).","journal-title":"Cell"},{"key":"237_CR65","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3389\/fmicb.2019.00962","volume":"10","author":"M Rao","year":"2019","unstructured":"Rao, M., Dodoo, E., Zumla, A. & Maeurer, M. Immunometabolism and pulmonary infections: implications for protective immune responses and host-directed therapies. Front. Microbiol. 10, 962 (2019).","journal-title":"Front. Microbiol."},{"key":"237_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.R115.693903","volume":"291","author":"RM Loftus","year":"2016","unstructured":"Loftus, R. M. & Finlay, D. K. Immunometabolism: cellular metabolism turns immune regulator. J. Biol. Chem. 291, 1\u201310 (2016).","journal-title":"J. Biol. Chem."},{"key":"237_CR67","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Metabolic instruction of immunity. Cell 169, 570\u2013586 (2017).","journal-title":"Cell"},{"key":"237_CR68","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"},{"key":"237_CR69","doi-asserted-by":"crossref","first-page":"e14019","DOI":"10.14814\/phy2.14019","volume":"7","author":"CL Vigeland","year":"2019","unstructured":"Vigeland, C. L. et al. Inhibition of glutamine metabolism accelerates resolution of acute lung injury. Physiol. Rep. 7, e14019 (2019).","journal-title":"Physiol. Rep."},{"key":"237_CR70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/nu8020076","volume":"8","author":"GP Oliveira","year":"2016","unstructured":"Oliveira, G. P., de Abreu, M. G., Pelosi, P. & Rocco, P. R. Exogenous glutamine in respiratory diseases: myth or reality? Nutrients 8, 76 (2016).","journal-title":"Nutrients"},{"key":"237_CR71","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.3390\/v4123440","volume":"4","author":"HJ Maier","year":"2012","unstructured":"Maier, H. J. & Britton, P. Involvement of autophagy in coronavirus replication. Viruses 4, 3440\u20133451 (2012).","journal-title":"Viruses"},{"key":"237_CR72","doi-asserted-by":"publisher","unstructured":"Acharya, D., Liu, G. & Gack, M. U. Dysregulation of type I interferon responses in COVID-19. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/s41577-020-0346-x (2020).","DOI":"10.1038\/s41577-020-0346-x"},{"key":"237_CR73","doi-asserted-by":"publisher","unstructured":"Lechien, J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Otorhinolaryngol. https:\/\/doi.org\/10.1007\/s00405-020-05965-1 (2020).","DOI":"10.1007\/s00405-020-05965-1"},{"key":"237_CR74","first-page":"1","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti, P. et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J. Biol. Regul. Homeost. Agents 34, 1 (2020).","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"237_CR75","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature 496, 238\u2013242 (2013).","journal-title":"Nature"},{"key":"237_CR76","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cmet.2019.01.014","volume":"29","author":"AE Rodriguez","year":"2019","unstructured":"Rodriguez, A. E. et al. Serine metabolism supports macrophage IL-1\u03b2 production. Cell Metab. 29, 1003\u20131011.e1004 (2019).","journal-title":"Cell Metab."},{"key":"237_CR77","doi-asserted-by":"crossref","first-page":"eaaz7086","DOI":"10.1126\/sciadv.aaz7086","volume":"6","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. O-GlcNAc transferase promotes influenza A virus\u2013induced cytokine storm by targeting interferon regulatory factor\u20135. Sci. Adv. 6, eaaz7086 (2020).","journal-title":"Sci. Adv."},{"key":"237_CR78","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/mmi.12149","volume":"87","author":"CC Hung","year":"2013","unstructured":"Hung, C. C. et al. The intestinal fatty acid propionate inhibits Salmonella invasion through the post-translational control of HilD. Mol. Microbiol. 87, 1045\u20131060 (2013).","journal-title":"Mol. Microbiol."},{"key":"237_CR79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1750-2659.2010.00155.x","volume":"4","author":"CE Moseley","year":"2010","unstructured":"Moseley, C. E., Webster, R. G. & Aldridge, J. R. Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice. Influenza Other Respir. Viruses 4, 307\u2013311 (2010).","journal-title":"Influenza Other Respir. Viruses"},{"key":"237_CR80","doi-asserted-by":"publisher","unstructured":"Kimmig, L. M. et al. IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.05.15.20103531 (2020).","DOI":"10.1101\/2020.05.15.20103531"},{"key":"237_CR81","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1165\/rcmb.2018-0152OC","volume":"60","author":"H Cui","year":"2019","unstructured":"Cui, H. et al. Impairment of fatty acid oxidation in alveolar epithelial cells mediates acute lung injury. Am. J. Respir. Cell Mol. Biol. 60, 167\u2013178 (2019).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"237_CR82","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","volume":"20","author":"RB Vega","year":"2000","unstructured":"Vega, R. B., Huss, J. M. & Kelly, D. P. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20, 1868\u20131876 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"237_CR83","doi-asserted-by":"crossref","first-page":"e1001665","DOI":"10.1371\/journal.pbio.1001665","volume":"11","author":"T Eckle","year":"2013","unstructured":"Eckle, T. et al. HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium. PLoS Biol. 11, e1001665 (2013).","journal-title":"PLoS Biol."},{"key":"237_CR84","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ajpath.2012.11.022","volume":"182","author":"J Xing","year":"2013","unstructured":"Xing, J. et al. Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo. Am. J. Pathol. 182, 1021\u20131030 (2013).","journal-title":"Am. J. Pathol."},{"key":"237_CR85","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1165\/rcmb.2016-0011PS","volume":"54","author":"MB Fessler","year":"2016","unstructured":"Fessler, M. B. & Summer, R. S. Surfactant lipids at the host-environment interface. Metabolic sensors, suppressors, and effectors of inflammatory lung disease. Am. J. Respir. Cell Mol. Biol. 54, 624\u2013635 (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"237_CR86","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/rr86","volume":"2","author":"A G\u00fcnther","year":"2001","unstructured":"G\u00fcnther, A. et al. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir. Res. 2, 353\u2013364 (2001).","journal-title":"Respir. Res."},{"key":"237_CR87","doi-asserted-by":"crossref","DOI":"10.1186\/s40635-019-0233-6","volume":"7","author":"FS Bezerra","year":"2019","unstructured":"Bezerra, F. S. et al. Exogenous surfactant prevents hyperoxia-induced lung injury in adult mice. Intensive Care Med. Exp. 7, 19 (2019).","journal-title":"Intensive Care Med. Exp."},{"key":"237_CR88","doi-asserted-by":"crossref","first-page":"e00182","DOI":"10.1016\/j.heliyon.2016.e00182","volume":"2","author":"L Oruqaj","year":"2016","unstructured":"Oruqaj, L. et al. Effect of high fat diet on pulmonary expression of parathyroid hormone-related protein and its downstream targets. Heliyon 2, e00182 (2016).","journal-title":"Heliyon"},{"key":"237_CR89","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1164\/rccm.201009-1409OC","volume":"183","author":"M Jain","year":"2011","unstructured":"Jain, M. et al. Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-\u03b3. Am. J. Respir. Crit. Care Med. 183, 1490\u20131498 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"237_CR90","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00408-003-1048-4","volume":"182","author":"LS Inselman","year":"2004","unstructured":"Inselman, L. S., Chander, A. & Spitzer, A. R. Diminished lung compliance and elevated surfactant lipids and proteins in nutritionally obese young rats. Lung 182, 101\u2013117 (2004).","journal-title":"Lung"},{"key":"237_CR91","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1128\/MCB.05114-11","volume":"31","author":"GA Gusarova","year":"2011","unstructured":"Gusarova, G. A. et al. Hypoxia leads to Na,K-ATPase downregulation via Ca2+ release-activated Ca2+ channels and AMPK activation. Mol. Cell. Biol. 31, 3546\u20133556 (2011).","journal-title":"Mol. Cell. Biol."},{"key":"237_CR92","doi-asserted-by":"crossref","first-page":"e10178","DOI":"10.1073\/pnas.1712837114","volume":"114","author":"ND Magnani","year":"2017","unstructured":"Magnani, N. D. et al. HIF and HOIL-1L-mediated PKC\u03b6 degradation stabilizes plasma membrane Na,K-ATPase to protect against hypoxia-induced lung injury. Proc. Natl Acad. Sci. USA 114, e10178\u2013e10186 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"237_CR93","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi, H. et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect. Dis. 20, 425\u2013434 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"237_CR94","volume":"4","author":"H Sunaga","year":"2013","unstructured":"Sunaga, H. et al. Deranged fatty acid composition causes pulmonary fibrosis in Elovl6-deficient mice. Nat. Commun. 4, 2563 (2013).","journal-title":"Nat. Commun."},{"key":"237_CR95","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201310-1917OC","volume":"189","author":"LS Huang","year":"2014","unstructured":"Huang, L. S. et al. The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 189, 1402\u20131415 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"237_CR96","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1165\/rcmb.2017-0340OC","volume":"59","author":"F Romero","year":"2018","unstructured":"Romero, F. et al. Lipid synthesis is required to resolve endoplasmic reticulum stress and limit fibrotic responses in the lung. Am. J. Respir. Cell Mol. Biol. 59, 225\u2013236 (2018).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"237_CR97","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1165\/rcmb.2018-0324OC","volume":"61","author":"SG Chu","year":"2019","unstructured":"Chu, S. G. et al. Palmitic acid-rich high-fat diet exacerbates experimental pulmonary fibrosis by modulating endoplasmic reticulum stress. Am. J. Respir. Cell Mol. Biol. 61, 737\u2013746 (2019).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"237_CR98","doi-asserted-by":"publisher","unstructured":"Shi, S. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.0950 (2020).","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"237_CR99","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok, F. A. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 191, 145\u2013147 (2020).","journal-title":"Thromb. Res."},{"key":"237_CR100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/eurjhf\/hfr173","volume":"14","author":"H Ardehali","year":"2012","unstructured":"Ardehali, H. et al. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur. J. Heart Fail. 14, 120\u2013129 (2012).","journal-title":"Eur. J. Heart Fail."},{"key":"237_CR101","doi-asserted-by":"crossref","first-page":"H1521","DOI":"10.1152\/ajpheart.00974.2002","volume":"284","author":"PN Chavez","year":"2003","unstructured":"Chavez, P. N. et al. Effect of hyperglycemia and fatty acid oxidation inhibition during aerobic conditions and demand-induced ischemia. Am. J. Physiol. Heart Circ. Physiol. 284, H1521\u2013H1527 (2003).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"237_CR102","doi-asserted-by":"crossref","first-page":"e102828","DOI":"10.5812\/ircmj.102828","volume":"22","author":"N Karimi","year":"2020","unstructured":"Karimi, N., Sharifi Razavi, A. & Rouhani, N. Frequent convulsive seizures in an adult patient with COVID-19: a case report. Iran. Red Crescent Med. J. 22, e102828 (2020).","journal-title":"Iran. Red Crescent Med. J."},{"key":"237_CR103","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fncel.2018.00274","volume":"12","author":"T McDonald","year":"2018","unstructured":"McDonald, T., Puchowicz, M. & Borges, K. Impairments in oxidative glucose metabolism in epilepsy and metabolic treatments thereof. Front. Cell. Neurosci. 12, 274 (2018).","journal-title":"Front. Cell. Neurosci."},{"key":"237_CR104","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/SHK.0b013e318240b52a","volume":"37","author":"HW Hsiao","year":"2012","unstructured":"Hsiao, H. W. et al. The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock 37, 289\u2013296 (2012).","journal-title":"Shock"},{"key":"237_CR105","doi-asserted-by":"crossref","first-page":"e100912","DOI":"10.1371\/journal.pone.0100912","volume":"9","author":"RR Bartz","year":"2014","unstructured":"Bartz, R. R. et al. Staphylococcus aureus sepsis induces early renal mitochondrial DNA repair and mitochondrial biogenesis in mice. PLoS ONE 9, e100912 (2014).","journal-title":"PLoS ONE"},{"key":"237_CR106","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jss.2014.10.009","volume":"194","author":"DA Escobar","year":"2015","unstructured":"Escobar, D. A. et al. Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation. J. Surg. Res. 194, 262\u2013272 (2015).","journal-title":"J. Surg. Res."},{"key":"237_CR107","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/cvr\/cvr038","volume":"90","author":"V Lionetti","year":"2011","unstructured":"Lionetti, V., Stanley, W. C. & Recchia, F. A. Modulating fatty acid oxidation in heart failure. Cardiovasc. Res. 90, 202\u2013209 (2011).","journal-title":"Cardiovasc. Res."},{"key":"237_CR108","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00467-010-1602-2","volume":"26","author":"AB Fogo","year":"2011","unstructured":"Fogo, A. B. PPAR\u03b3 and chronic kidney disease. Pediatr. Nephrol. 26, 347\u2013351 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"237_CR109","doi-asserted-by":"crossref","first-page":"1072805","DOI":"10.1155\/2018\/1072805","volume":"2018","author":"JH Park","year":"2018","unstructured":"Park, J. H. et al. Effects of post ischemia-reperfusion treatment with trimetazidine on renal injury in rats: insights on delayed renal fibrosis progression. Oxid. Med. Cell. Longev. 2018, 1072805 (2018).","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-0237-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-0237-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-0237-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:40:30Z","timestamp":1723156830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-0237-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":109,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["237"],"URL":"https:\/\/doi.org\/10.1038\/s42255-020-0237-2","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}